Literature DB >> 8405375

Participation of cathepsin B in processing of antigen presentation to MHC class II.

Y Matsunaga1, T Saibara, H Kido, N Katunuma.   

Abstract

Cellular and humoral immune responses to vaccines of hepatitis B type and rabies were inhibited by specific inhibitors of cathepsin B, specific synthetic substrates of cathepsin B and anti-cathepsin B antibody. Therefore the lysosomal cathepsin B of antigen presenting cells plays an essential role in processing of these antigens for presentation to MHC class II. One of the active sites of cathepsin B, VN217-222 shares highly homologous sequences with a part of the desetope, a binding domain of antigenic peptides, VN57-62 of MHC class II, beta-chain. This evidence suggests that the peptides processed by the substrate specificity of cathepsin B exhibit a common affinity to bind with the desetope of MHC class II, beta-chain.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8405375     DOI: 10.1016/0014-5793(93)80144-j

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  17 in total

1.  HLA-DR peptide occupancy can be regulated with a wide variety of small molecules.

Authors:  Francesca Blazekovic; Dana Odukoya; Shanitra N Butler; James A Mauro; Michael Ramsamooj; Erika Puleo; Karoly Szekeres; Dibyendu Dana; Sanjai Kumar; Govind Ragupathi; George Blanck
Journal:  Hum Vaccin Immunother       Date:  2016-03-03       Impact factor: 3.452

2.  Increased proteolysis of diphtheria toxin by human monocytes after heat shock: a subsidiary role for heat-shock protein 70 in antigen processing.

Authors:  Barbara S Polla; Françoise Gabert; Brigitte M-N Peyrusse; Muriel R Jacquier-Sarlin
Journal:  Immunology       Date:  2006-11-20       Impact factor: 7.397

3.  Proteolytic mechanisms of cartilage breakdown: a target for arthritis therapy?

Authors:  D J Buttle; H Bramwell; A P Hollander
Journal:  Clin Mol Pathol       Date:  1995-08

4.  Uveitogenic epitopes of retinal S-antigen are generated in vivo via an alternative antigen-presentation pathway.

Authors:  J Liversidge; R Dawson; A D Dick; J V Forrester
Journal:  Immunology       Date:  1998-06       Impact factor: 7.397

5.  Effect of the selective and non-selective cysteine protease inhibitors on the intracellular processing of interleukin 6 by HEPG2 cells.

Authors:  J V Peppard; A K Knap
Journal:  In Vitro Cell Dev Biol Anim       Date:  1999-09       Impact factor: 2.416

6.  Importance of thioredoxin in the proteolysis of an immunoglobulin G as antigen by lysosomal Cys-proteases.

Authors:  I Kerblat; C Drouet; S Chesne; P N Marche
Journal:  Immunology       Date:  1999-05       Impact factor: 7.397

7.  Cathepsin B regulates the appearance and severity of mercury-induced inflammation and autoimmunity.

Authors:  Christopher B Toomey; David M Cauvi; John C Hamel; Andrea E Ramirez; K Michael Pollard
Journal:  Toxicol Sci       Date:  2014-09-18       Impact factor: 4.849

8.  Cathepsin S inhibitor prevents autoantigen presentation and autoimmunity.

Authors:  Kaoru Saegusa; Naozumi Ishimaru; Kumiko Yanagi; Rieko Arakaki; Kouichi Ogawa; Ichiro Saito; Nobuhiko Katunuma; Yoshio Hayashi
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

9.  Cathepsin S activity regulates antigen presentation and immunity.

Authors:  R J Riese; R N Mitchell; J A Villadangos; G P Shi; J T Palmer; E R Karp; G T De Sanctis; H L Ploegh; H A Chapman
Journal:  J Clin Invest       Date:  1998-06-01       Impact factor: 14.808

10.  A double-headed cathepsin B inhibitor devoid of warhead.

Authors:  Patricia Schenker; Pietro Alfarano; Peter Kolb; Amedeo Caflisch; Antonio Baici
Journal:  Protein Sci       Date:  2008-09-16       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.